Not applicableLooking for participantsNCT05278494What this trial is testingDextromethorphan for Treatment of Postoperative PainWho this might be right forPost-operative Pain Nathanael Heckmann 160
Not applicableStudy completedNCT00199303What this trial is testingEfficacy of Pre- and Post-Operative Oral DextromethorphanWho this might be right forEfficacy of DextromethorphanMorphine ConsumptionPain Khon Kaen University 100
Large-scale testing (Phase 3)Study completedNCT00113620What this trial is testingSafety and Efficacy of Dextromethorphan and Quinidine in the Treatment of the Pain of Diabetic NeuropathyWho this might be right forPainDiabetic Neuropathy Avanir Pharmaceuticals 450
Early research (Phase 1)Study completedNCT00535951What this trial is testingPharmacokinetic, Safety, and Efficacy Effects of Oral LBH589 on Dextromethorphan in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer or Malignant Pleural MesotheliomaWho this might be right forCarcinoma, Non-Small-Cell LungMesothelioma Novartis Pharmaceuticals 18
Post-approval studies (Phase 4)Study completedNCT03738917What this trial is testingEffectiveness of Antitussives, Anticholinergics and Honey Versus Usual Care in Adults With Acute Bronchitis.Who this might be right forAcute Bronchitis Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina 668
Large-scale testing (Phase 3)Study completedNCT05557409What this trial is testingAssess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease AgitationWho this might be right forAgitation in Patients With Dementia of the Alzheimer's TypeAlzheimer DiseaseAgitation Axsome Therapeutics, Inc. 408
Not applicableActive Not RecruitingNCT06957223What this trial is testingEfficacy of Dextromethorphan-Bupropion Versus SSRIs in the Treatment of Major Depressive DisorderWho this might be right forMajor Depressive Disorder (MDD) Asad Ullah Jan 80
Post-approval studies (Phase 4)Looking for participantsNCT06223880What this trial is testingEvaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive SymptomsWho this might be right forMajor Depressive Disorder Axsome Therapeutics, Inc. 350
Testing effectiveness (Phase 2)Study completedNCT02153502What this trial is testingEfficacy, Safety, and Tolerability Study of AVP-786 as an Adjunctive Therapy in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant TreatmentWho this might be right forDepressive Disorder, Treatment-Resistant Avanir Pharmaceuticals 206
Large-scale testing (Phase 3)Study completedNCT04039022What this trial is testingOpen-Label Safety Study of AXS-05 in Subjects With DepressionWho this might be right forMajor Depressive DisorderTreatment Resistant DepressionDepression Axsome Therapeutics, Inc. 876
Large-scale testing (Phase 3)Study completedNCT00021697What this trial is testingSafety/Efficacy of AVP-923 in the Treatment of Emotional Lability (Uncontrolled Crying & Laughing) in Patients With ALSWho this might be right forAmyotrophic Lateral Sclerosis Avanir Pharmaceuticals 100
Large-scale testing (Phase 3)Ended earlyNCT02446132What this trial is testingLong Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's TypeWho this might be right forAgitation in Patients With Dementia of the Alzheimer's Type Otsuka Pharmaceutical Development & Commercialization, Inc. 1,197
Testing effectiveness (Phase 2)Ended earlyNCT04634669What this trial is testingOpen-Label Safety Study of AXS-05 in Subjects With TRD (EVOLVE)Who this might be right forTreatment Resistant DepressionMajor Depressive Disorder Axsome Therapeutics, Inc. 181
Large-scale testing (Phase 3)Study completedNCT01189006What this trial is testingAdd-On Therapy to Risperidonein SchizophreniaWho this might be right forSchizophrenia National Cheng-Kung University Hospital 161
Testing effectiveness (Phase 2)Study completedNCT01584440What this trial is testingEfficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Participants With Alzheimer's DiseaseWho this might be right forAgitationAlzheimer's Disease Avanir Pharmaceuticals 220
Post-approval studies (Phase 4)Ended earlyNCT01832350What this trial is testingNuedexta in the Treatment of Pseudobulbar Affect in Patients With Alzheimer's DiseaseWho this might be right forAlzheimer's DiseasePseudobulbar Affect (PBA) St. Joseph's Hospital and Medical Center, Phoenix 34
Post-approval studies (Phase 4)Ended earlyNCT01257542What this trial is testingAcute Cough Study In ChildrenWho this might be right forCommon ColdInfections, Upper Respiratory Tract Pfizer 140
Large-scale testing (Phase 3)Study completedNCT02442778What this trial is testingEfficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Participants With Dementia of the Alzheimer's TypeWho this might be right forAgitation in Participants With Dementia of the Alzheimer's Type Otsuka Pharmaceutical Development & Commercialization, Inc. 522
Not applicableUnknownNCT01553435What this trial is testingEffect of N-methyl D-aspartate (NMDA) Receptor Antagonist Dextromethorphan on Opiods Analgesia and Tolerance in Pediatric Intensive Care Unit PatientsWho this might be right forPainOpioid ToleranceAnalgesia Tolerance King Abdullah International Medical Research Center 36
Large-scale testing (Phase 3)Study completedNCT00573443What this trial is testingSafety and Efficacy of AVP-923 in PBA Patients With ALS or MSWho this might be right forPseudobulbar Affect (PBA) Avanir Pharmaceuticals 326